DIVI S LABORATORIES LTD (DIVISLAB) financials

DIVI S LABORATORIES LTD (DIVISLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients[1]

Market Cap: ₹2,42,758Cr.
Current Price: ₹9,144
Stock P/E: 81.0
ROE: 16.8%
ROCE: 22.4%
Book Value: ₹629
Dividend Yield: 0.33%
52W High / Low: ₹10,000/5,648

In Jun 2026, DIVI S LABORATORIES LTD (DIVISLAB) reported sales ₹2,974 Cr and net profit ₹891 Cr.

Annual TTM: sales ₹11,005 Cr, net profit ₹2,941 Cr.

Shareholding: Promoters 51.87% (Sep 2026), FIIs 20.38% (Sep 2026), DIIs 19.08% (Sep 2026), Government 0.09% (Sep 2026), Public 8.58% (Sep 2026).

DIVISLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2,302	2,297	2,536	2,357	2,660	2,578	2,793	2,974
Expenses	1,573	1,550	1,655	1,614	1,765	1,671	1,850	1,734
Operating Profit	729	747	881	743	895	907	943	1,240
OPM %	32%	33%	35%	32%	34%	35%	34%	42%
Other Income	105	82	87	119	146	13	154	63
Interest	1	0	0	3	8	6	6	6
Depreciation	98	99	107	112	113	116	120	132
Profit before tax	735	730	861	747	920	798	971	1,165
Tax %	30%	19%	23%	25%	24%	25%	22%	24%
Net Profit	518	594	667	557	696	598	756	891
EPS in Rs	19.51	22.38	25.13	20.98	26.22	22.53	28.48	33.56
Raw PDF	—	—	—	—	—	—	—	—

DIVISLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	5,311	6,799	8,880	7,625	7,665	9,198	10,388	11,005
Expenses	3,491	3,971	5,000	5,275	5,486	6,214	6,899	7,020
Operating Profit	1,820	2,828	3,880	2,350	2,179	2,984	3,489	3,985
OPM %	34%	42%	44%	31%	28%	32%	34%	36%
Other Income	187	57	109	348	333	348	432	376
Interest	7	2	2	2	4	2	24	26
Depreciation	186	255	311	342	376	401	461	481
Profit before tax	1,813	2,628	3,677	2,354	2,132	2,929	3,436	3,854
Tax %	24%	26%	20%	23%	26%	25%	24%	—
Net Profit	1,373	1,955	2,949	1,808	1,576	2,209	2,607	2,941
EPS in Rs	51.71	73.63	111.07	68.11	59.37	83.21	98.20	110.79
Dividend Payout %	31%	27%	27%	44%	50%	36%	30%	—

DIVISLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	53	53	53	53	53	53	53	53
Reserves	6,920	7,264	9,218	11,638	12,652	13,431	14,842	16,658
Borrowings	106	34	0	0	0	0	2	0
Other Liabilities	961	1,164	1,452	1,617	1,647	1,878	1,927	3,243
Total Liabilities	8,040	8,514	10,724	13,308	14,352	15,362	16,824	19,954
Fixed Assets	2,087	2,776	3,699	4,321	4,719	4,737	5,440	6,520
CWIP	492	920	711	470	212	778	1,022	2,113
Investments	1,953	979	7	79	84	89	72	76
Other Assets	3,508	3,839	6,307	8,438	9,337	9,758	10,290	11,245
Total Assets	8,040	8,514	10,724	13,308	14,352	15,362	16,824	19,954

DIVISLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	964	1,208	1,947	1,910	2,447	1,266	1,650	2,711
Cash from Investing Activity	-684	-81	75	-2,195	-2,707	-268	-803	-2,218
Cash from Financing Activity	-246	-1,091	-34	-532	-796	-798	-797	-802
Net Cash Flow	34	36	1,988	-817	-1,056	200	50	-309
Free Cash Flow	231	26	1,037	1,196	1,975	264	213	195
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	78%	91%	91%	65%	124%	75%	83%	102%

DIVISLAB shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	51.89%	51.89%	51.88%	51.88%	51.88%	51.88%	51.88%	51.87%
FIIs	17.98%	18.01%	19.74%	19.39%	20.08%	20.29%	20.19%	20.38%
DIIs	20.44%	20.63%	18.96%	19.68%	19.18%	19.13%	19.29%	19.08%
Government	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%
Public	9.58%	9.39%	9.32%	8.96%	8.75%	8.61%	8.53%	8.58%
No. of Shareholders	2,80,601	2,67,755	2,59,825	2,49,634	2,33,844	2,28,006	2,26,324	2,32,256

DIVISLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	96	105	94	106	94	108	113	113
Inventory Days	324	299	322	316	329	347	296	331
Days Payable	94	99	118	92	88	94	86	106
Cash Conversion Cycle	325	305	298	330	335	361	323	338
Working Capital Days	173	184	155	178	190	207	193	198
ROCE %	28%	24%	32%	35%	19%	16%	21%	22%

DIVISLABUpdated 18 Oct 2026, 5:20

Divi S Laboratories Ltd

DIVISLABUpdated 18 Oct 2026, 5:20

Market Cap

₹2,42,758Cr.

Current Price

₹9,144

High / Low

₹10,000/5,648

Stock P/E

81.0

ROE16.8%

ROCE22.4%

Book Value₹629

Face Value₹2.00

Dividend Yield0.33%

About

Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1730	0	1239	80	93	478	28	345	13
Sep 2023	1868	1	1394	85	94	464	26	342	12.88
Dec 2023	1808	0	1317	94	95	490	27	358	13.49
Mar 2024	2259	2	1542	79	94	700	24	531	20
Jun 2024	2063	0	1442	79	97	603	29	430	16.2
Sep 2024	2302	1	1573	105	98	735	30	518	19.51
Dec 2024	2297	0	1550	82	99	730	19	594	22.38
Mar 2025	2536	0	1655	87	107	861	23	667	25.13
Jun 2025	2357	3	1614	119	112	747	25	557	20.98
Sep 2025	2660	8	1765	146	113	920	24	696	26.22
Dec 2025	2578	6	1671	13	116	798	25	598	22.53
Mar 2026	2793	6	1850	154	120	971	22	756	28.48
Jun 2026	2974	6	1734	63	132	1165	24	891	33.56

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	3084	3	1914	36	136	1067	21	847	31.9
Mar 2016	3720	4	2314	92	118	1375	19	1111	41.84
Mar 2017	4024	3	2582	73	123	1388	24	1053	39.68
Mar 2018	3816	2	2558	106	142	1219	29	870	32.76
Mar 2019	4880	5	3028	155	169	1833	27	1333	50.2
Mar 2020	5311	7	3491	187	186	1813	24	1373	51.71
Mar 2021	6799	2	3971	57	255	2628	26	1955	73.63
Mar 2022	8880	2	5000	109	311	3677	20	2949	111.07
Mar 2023	7625	2	5275	348	342	2354	23	1808	68.11
Mar 2024	7665	4	5486	333	376	2132	26	1576	59.37
Mar 2025	9198	2	6214	348	401	2929	25	2209	83.21
Mar 2026	10388	24	6899	432	461	3436	24	2607	98.2
TTM	11005	26	7020	376	481	3854	—	2941	110.79

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	51.87%
FIIs	20.38%
DIIs	19.08%
Government	0.09%
Public	8.58%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	51.92%	14.85%	21.78%	0.1%	11.33%
Mar 2024	51.92%	14.68%	22.1%	0.1%	11.19%
Jun 2024	51.89%	16.16%	21.66%	0.1%	10.17%
Sep 2024	51.89%	17.25%	20.98%	0.09%	9.79%
Dec 2024	51.89%	17.98%	20.44%	0.09%	9.58%
Mar 2025	51.89%	18.01%	20.63%	0.09%	9.39%
Jun 2025	51.88%	19.74%	18.96%	0.09%	9.32%
Sep 2025	51.88%	19.39%	19.68%	0.09%	8.96%
Dec 2025	51.88%	20.08%	19.18%	0.09%	8.75%
Mar 2026	51.88%	20.29%	19.13%	0.09%	8.61%
Jun 2026	51.88%	20.19%	19.29%	0.09%	8.53%
Sep 2026	51.87%	20.38%	19.08%	0.09%	8.58%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	27	3535	27	886	4475	1309	218	736	2212	4475
Mar 2016	53	4304	42	566	4965	1439	264	813	2450	4965
Mar 2017	53	5356	36	765	6210	1559	444	1639	2568	6210
Mar 2018	53	5907	63	785	6808	1996	120	1897	2795	6808
Mar 2019	53	6920	106	961	8040	2087	492	1953	3508	8040
Mar 2020	53	7264	34	1164	8514	2776	920	979	3839	8514
Mar 2021	53	9218	0	1452	10724	3699	711	7	6307	10724
Mar 2022	53	11638	0	1617	13308	4321	470	79	8438	13308
Mar 2023	53	12652	0	1647	14352	4719	212	84	9337	14352
Mar 2024	53	13431	0	1878	15362	4737	778	89	9758	15362
Mar 2025	53	14842	2	1927	16824	5440	1022	72	10290	16824
Mar 2026	53	16658	0	3243	19954	6520	2113	76	11245	19954

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	822	-521	-303	-1
Mar 2016	1036	-411	-630	-5
Mar 2017	1149	-1137	3	15
Mar 2018	765	-476	-314	-25
Mar 2019	964	-684	-246	34
Mar 2020	1208	-81	-1091	36
Mar 2021	1947	75	-34	1988
Mar 2022	1910	-2195	-532	-817
Mar 2023	2447	-2707	-796	-1056
Mar 2024	1266	-268	-798	200
Mar 2025	1650	-803	-797	50
Mar 2026	2711	-2218	-802	-309

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	97	95	91	106	96	105	94	106	94	108	113	113
Inventory Days	335	284	291	311	324	299	322	316	329	347	296	331
Days Payable	67	56	103	98	94	99	118	92	88	94	86	106
Cash Conversion Cycle	365	323	280	319	325	305	298	330	335	361	323	338
Working Capital Days	146	165	153	185	173	184	155	178	190	207	193	198
ROCE %	32%	35%	28%	21%	28%	24%	32%	35%	19%	16%	21%	22%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of DIVI S LABORATORIES LTD (DIVISLAB)?

The reported market capitalisation for DIVI S LABORATORIES LTD (DIVISLAB) is ₹2,42,758Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of DIVISLAB?

The current price shown for DIVI S LABORATORIES LTD (DIVISLAB) on Fincrux is ₹9,144 with a 52-week high/low of ₹10,000/5,648.

What is the P/E ratio of DIVI S LABORATORIES LTD (DIVISLAB)?

The stock P/E for DIVI S LABORATORIES LTD (DIVISLAB) is 81.0 on Fincrux, with ROE at 16.8% and ROCE at 22.4%.

What were DIVISLAB latest quarterly results?

For Jun 2026, DIVI S LABORATORIES LTD (DIVISLAB) reported sales ₹2,974 Cr and net profit ₹891 Cr (figures in ₹ crore unless noted).

What are DIVISLAB annual sales and net profit?

For TTM, DIVI S LABORATORIES LTD (DIVISLAB) shows sales of ₹11,005 Cr and net profit of ₹2,941 Cr on the Fincrux profit & loss statement.

Who owns DIVI S LABORATORIES LTD (DIVISLAB)?

Latest shareholding for DIVI S LABORATORIES LTD (DIVISLAB) on Fincrux: Promoters 51.87% (Sep 2026), FIIs 20.38% (Sep 2026), DIIs 19.08% (Sep 2026), Government 0.09% (Sep 2026), Public 8.58% (Sep 2026).

Where can I find DIVI S LABORATORIES LTD (DIVISLAB) financials?

DIVI S LABORATORIES LTD (DIVISLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show DIVISLAB balance sheet and cash flow?

Yes. The DIVI S LABORATORIES LTD (DIVISLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 5:20